StemCell Institute
7096.TPharmaceutical
In English · 4
Mon, Mar 3 · JST1 filing
16:005% STAKEStemCell Institute · NIHON TRIM CO., LTD. · 72.06% → 70.02%−2.04ppAll EDINET filings · 45
| Filed | Document | Source |
|---|---|---|
| 2026-06-23 | Internal control report | S100YI7K |
| 2026-06-23 | CEO/CFO certification | S100YI73 |
| 2025-12-01 | Share buyback report | S100X7WT |
| 2025-11-14 | CEO/CFO certification | S100X48Y |
| 2025-11-04 | Share buyback report | S100WYGH |
| 2025-10-01 | Share buyback report | S100WSLV |
| 2025-06-24 | Internal control report | S100W2WA |
| 2025-06-24 | CEO/CFO certification | S100W2W5 |
| 2024-11-14 | CEO/CFO certification | S100URSZ |
| 2024-06-27 | Internal control report | S100TW7M |
| 2024-06-27 | CEO/CFO certification | S100TW6I |
| 2024-02-09 | CEO/CFO certification | S100SSNY |
| 2023-11-10 | CEO/CFO certification | S100S791 |
| 2023-06-26 | Internal control report | S100R3FD |
| 2023-06-26 | CEO/CFO certification | S100R3F5 |
| 2022-06-24 | Internal control report | S100OCYK |
| 2022-06-24 | CEO/CFO certification | S100OCXC |
EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected. 4 financial reports not structured yet.